CytoNiche Expands U.S. FDA Regulatory Filings For 3D RecomTrix Recombinant Collagen Microcarriers

Singapore, Singapore, 28th Aug 2026 — ( KOREWIRE ) - CytoNiche Biotech, a pioneer in advanced 3D cell manufacturing technologies, announced a pivotal regulatory milestone in its global expansion strategy. The company’s proprietary 3D RecomTrix recombinant collagen microcarriers (CW01) have...